ESAB earnings release, August 6, 2026
ESAB Corporation Announces Second Quarter 2026 Results
• Record total sales increased 12.9%, with core organic sales up 2.5%
• Core organic growth in both segments
• Closed Eddyfi ahead of schedule
• Updating 2026 outlook
North Bethesda, MD, August 6, 2026 -- ESAB Corporation (“ESAB” or the “Company”) (NYSE: ESAB), a focused premier industrial compounder, today announced financial results for the second quarter of 2026.
ESAB reported record second quarter sales of $808 million, an increase of 12.9% on a reported basis or an increase of 2.5% on a core organic growth basis before acquisitions and currency translation, as compared to the prior year quarter. ESAB also reported second quarter net income from continuing operations attributable to ESAB of $35 million or $0.54 diluted earnings per share and core adjusted net income of $83 million or $1.33 diluted earnings per share, down 1% on a year-over-year basis. Core adjusted EBITDA of $150 million rose 8.0% and core adjusted EBITDA margin decreased by 90 basis points on a year-over-year basis to 19.5%, reflecting transitory price/cost neutrality, and targeted commercial investments for equipment growth.
"ESAB delivered a record second quarter, with a solid return to organic growth in both regions, underscoring the strength of our platform even in a challenging macro environment. These results reflect the strength of our teams and the value of our unrivaled workflow solution that addresses our customers' most complex issues. Despite a challenging environment in the Middle East, our performance exceeded expectations, with particular strength in North America and Asia and a resilient Europe. We expect to mitigate the transitory cost inflation related to logistics and commodity price increases over the next few quarters," said Shyam P. Kambeyanda, ESAB President and CEO.
"We are also pleased to have closed our acquisition of Eddyfi one month ahead of schedule," Kambeyanda added. "This is a defining step in our strategy to extend our workflow solutions into compelling new adjacencies that shape ESAB into a higher-growth, higher-margin enterprise. Our performance this quarter reaffirms my full confidence in achieving our long-term financial targets as we continue to focus on organic growth, margin expansion, and deleveraging the business to create sustainable, long-term shareholder value."
Updating Full Year 2026 Outlook
ESAB has updated its full-year 2026 outlook, which now projects total core sales growth of 11.0% to 14.0%, an increase from the previous guidance of 6.0% to 9.0%. Within this growth, core organic sales remains 2.0% to 4.0%, while the contribution from M&A has been revised upward to approximately 9.0% from 4.0%, and the anticipated FX impact has remained the same with the prior range of 0.0% to 1.0%. Consequently, the company has raised its core adjusted EBITDA forecast to a range of $615 million to $625 million, up from the previous $575 million to $595 million, while the outlook for core adjusted EPS has been adjusted to a range of $5.40 to $5.50.
About ESAB Corporation
Founded in 1904, ESAB Corporation is a focused industrial compounder. The Company’s rich history of innovative products, workflow solutions and its business system ESAB Business Excellence (“EBXai”), enables the Company’s purpose of
Shaping the world we imagine
TM. ESAB Corporation is based in North Bethesda, Maryland and employs approximately 11,300 associates and serves customers in approximately 150 countries. To learn more, visit www.ESABcorporation.com.
Conference Call and Webcast
The Company will hold a conference call to discuss its second quarter 2026 results beginning at 8:00 a.m. Eastern on Thursday, August 6, 2026, which will be open to the public by calling +1-888-550-5302 (U.S. callers) and +1-646-960-0685 (International callers) and referencing the conference ID number 4669992 and through webcast via ESAB’s website www.ESABcorporation.com under the “Investors” section. Access to a supplemental slide presentation can also be found on ESAB's website under the same heading. Both the audio of this call and the slide presentation will be archived on the website later today and will be available until the next quarterly call.
The Company’s quarterly report on Form 10-Q for the fiscal quarter ended July 3, 2026, filed August 6, 2026, is also available on ESAB’s website under the “Investors” section.¹
Non-GAAP Financial Measures and Other Adjustments
ESAB has provided in this press release financial information that has not been prepared in accordance with accounting principles generally accepted in the United States (“non-GAAP”). ESAB presents some of these non-GAAP financial measures including and excluding Russia d ue to economic and political volatility caused by the war in Ukraine, which results in enhanced investor interest in this information. Core non-GAAP financial measures exclude Russia for the three and six months ended July 3, 2026 and
July 4, 2025. T hese non-GAAP financial measures may include one or more of the following: adjusted net income from continuing operations, Core adjusted net income from continuing operations, adjusted EBITDA (earnings before interest, taxes, Restructuring and other related charges, acquisition transaction, due diligence and integration expenses, amortization of intangibles and fair value step up on acquired inventories, depreciation and other amortization and compensation expense related to the Performance Option Awards), Core adjusted EBITDA, organic sales, Core organic sales, adjusted free cash flow and ratios based on the foregoing measures. ESAB also provides adjusted EBITDA and adjusted EBITDA margin on a segment basis, as well as Core adjusted EBITDA and Core adjusted EBITDA margin on a segment basis.... (truncated)ransaction, due diligence and integration expenses, amortization of intangibles and fair value step up on acquired inventories and compensation expense related to the Performance Option Awards. Adjusted net income, includes the tax effect of non-GAAP adjusting items at applicable tax rates and excludes the impact of discrete tax charges or gains in each period. ESAB also presents adjusted net income margin from continuing operations, which is subject to the same adjustments as adjusted net income from continuing operations. Adjusted net income per diluted share from continuing operations is a calculation of adjusted net income from continuing operations over the weighted-average diluted shares outstanding. ESAB also presents Core adjusted net income from continuing operations and Core adjusted net income per share - diluted from continuing operations, which are subject to the same adjustments as Adjusted net income from continuing operations and Adjusted net income per diluted share from continuing operations, further removing the impact of Russia for the three and six months ended July 3, 2026 and July 4, 2025. We present the earnings per share-related non-GAAP measures on a basis that assumes the MCPS had already been converted as of the beginning of the applicable period (and accordingly also exclude the dividends accrued on the MCPS during such period, since such dividends would no longer be paid once the MCPS convert). We believe this presentation provides useful information to investors by helping them understand what the net impact will be on ESAB’s earnings per share - related measures once the MCPS convert into ESAB’s common stock.
Adjusted EBITDA excludes from Net income from continuing operations the effect of Income tax expense, Interest expense and other, net, Restructuring and other related charges, acquisition transaction, due diligence and integration expenses, amortization of intangibles and fair value step up on acquired inventories, depreciation and other amortization and compensation expense related to the Performance Option Awards. ESAB presents adjusted EBITDA margin, which is subject to the same adjustments as adjusted EBITDA. Further, ESAB presents these non-GAAP performance measures on a segment basis, which excludes the impact of Restructuring and other related charges, acquisition transaction, due diligence and integration expenses, amortization of intangibles and fair value step up on acquired inventories, depreciation and other amortization and compensation expense related to the Performance Option Awards from operating income. ESAB also presents Core adjusted EBITDA and Core adjusted EBITDA margin, which are subject to the same adjustments as Ad justed EBITDA and Adjusted EBITDA margin, respectively, further removing the impact of Russia for the three and six months ended July 3, 2026 and
July 4, 2025.
ESAB presents organic sales, which excludes the impact of acquisitions and foreign exchange rate fluctuations and presents core organic sales, which further excludes the impact of the Russia business for the three and six months ended July 3, 2026 and
July 4, 2025.
Adjusted free cash flow represents cash flows from operating activities excluding cash outflows related to discontinued operations and acquisition-related payments less purchases of property, plant and equipment.
These non-GAAP financial measures assist ESAB management in comparing its operating performance over time because certain items may obscure underlying business trends and make comparisons of long-term performance difficult, as they are of a nature and/or size that occur with inconsistent frequency or relate to unusual events or discrete restructuring plans and other initiatives that are fundamentally different from the ongoing productivity and core business of the Company.
ESAB management also believes that presenting these measures allows investors to view its performance using the same measures that the Company uses in evaluating its financial and business performance and trends.²
Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information calculated in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures. A reconciliation of non-GAAP financial measures presented above to GAAP results has been provided in the financial tables included in this press release.
Financial statements
Income Statement
Three Months Ended — (Unaudited)
| Three Months Ended – July 3, 2026 | Three Months Ended – July 4, 2025 | Six Months Ended – July 3, 2026 | Six Months Ended – July 4, 2025 | ||
|---|---|---|---|---|---|
| Net sales | 807,627 | 715,586 | 1,553,224 | 1,393,724 | |
| Cost of sales | 500,416 | 449,539 | 970,901 | 872,475 | |
| Gross profit | 307,211 | 266,047 | 582,323 | 521,249 | |
| Selling, general and administrative expense | 210,169 | 155,563 | 384,641 | 296,421 | |
| Restructuring and other related charges | 18,317 | 1,390 | 28,478 | 5,889 | |
| Operating income | 78,725 | 109,094 | 169,204 | 218,939 | |
| Interest expense and other, net | 30,623 | 20,999 | 56,200 | 37,781 | |
| Income from continuing operations before income taxes | 48,102 | 88,095 | 113,004 | 181,158 | |
| Income tax expense | 11,701 | 18,283 | 24,812 | 38,782 | |
| Net income from continuing operations | 36,401 | 69,812 | 88,192 | 142,376 | |
| Loss from discontinued operations, net of taxes | -2,413 | -1,708 | -4,967 | -4,440 | |
| Net income | 33,988 | 68,104 | 83,225 | 137,936 | |
| Income attributable to noncontrolling interest, net of taxes | -1,634 | -1,221 | -3,227 | -3,690 | |
| Net income attributable to ESAB Corporation | 32,354 | 66,883 | 79,998 | 134,246 | |
| Mandatory convertible preferred stock dividends | -1,390 | -1,390 | |||
| Net income attributable to common stockholders | 30,964 | 66,883 | 78,608 | 134,246 | |
| Earnings (loss) per share – basic | Income from continuing operations | 0.54 | 1.13 | 1.36 | 2.28 |
| Earnings (loss) per share – basic | Loss on discontinued operations | -0.04 | -0.03 | -0.08 | -0.07 |
| Earnings (loss) per share – basic | Net income per share – basic | 0.5 | 1.1 | 1.28 | 2.21 |
| Earnings (loss) per share – diluted | Income from continuing operations | 0.54 | 1.12 | 1.35 | 2.26 |
| Earnings (loss) per share – diluted | Loss on discontinued operations | -0.04 | -0.03 | -0.08 | -0.07 |
| Earnings (loss) per share – diluted | Net income per share – diluted | 0.5 | 1.09 | 1.27 | 2.19 |
Income Statement
EMEA & APAC — (Unaudited)
| Americas – Three Months Ended July 3, 2026(1) | EMEA & APAC – Three Months Ended July 3, 2026(1) | Total – Three Months Ended July 3, 2026(1) | Americas – Six Months Ended July 3, 2026(1) | EMEA & APAC – Six Months Ended July 3, 2026(1) | Total – Six Months Ended July 3, 2026(1) | ||
|---|---|---|---|---|---|---|---|
| Net income from continuing operations (GAAP) | 36.4 | 88.2 | |||||
| Income tax expense | 11.7 | 24.8 | |||||
| Interest expense and other, net | 30.6 | 56.2 | |||||
| Operating income (GAAP) | 22.5 | 56.2 | 78.7 | 57.7 | 111.5 | 169.2 | |
| Adjusted to add | Restructuring and other related charges(2) | 18.3 | 18.3 | 27.3 | 1.2 | 28.5 | |
| Adjusted to add | Acquisition-amortization and other related charges(3) | 18.2 | 23.1 | 41.3 | 25.9 | 38.3 | 64.1 |
| Adjusted to add | Depreciation and other amortization | 4.7 | 7.6 | 12.3 | 9 | 16.5 | 25.5 |
| Adjusted to add | Performance option awards compensation expense(4) | 0.3 | 0.4 | 0.7 | 0.3 | 0.4 | 0.7 |
| Adjusted to add | Adjusted EBITDA (non-GAAP) | 64 | 87.3 | 151.4 | 120 | 167.9 | 287.9 |
| Adjusted to add | Adjusted EBITDA attributable to Russia (non-GAAP)(5) | 1.8 | 1.8 | 2.5 | 2.5 | ||
| Adjusted to add | Core adjusted EBITDA (non-GAAP) | 64 | 85.5 | 149.6 | 120 | 165.4 | 285.5 |
| Adjusted to add | Adjusted EBITDA margin (non-GAAP) | 20.3 | 17.8 | 18.7 | 19.9 | 17.7 | 18.5 |
| Adjusted to add | Core adjusted EBITDA margin (non-GAAP)(6) | 20.3 | 19 | 19.5 | 19.9 | 18.8 | 19.3 |
Income Statement
EMEA & APAC — (Unaudited)
| Americas – Three Months Ended July 4, 2025(1) | EMEA & APAC – Three Months Ended July 4, 2025(1) | Total – Three Months Ended July 4, 2025(1) | Americas – Six Months Ended July 4, 2025(1) | EMEA & APAC – Six Months Ended July 4, 2025(1) | Total – Six Months Ended July 4, 2025(1) | ||
|---|---|---|---|---|---|---|---|
| Net income from continuing operations (GAAP) | 69.8 | 142.4 | |||||
| Income tax expense | 18.3 | 38.8 | |||||
| Interest expense and other, net | 21 | 37.8 | |||||
| Operating income (GAAP) | 42.4 | 66.7 | 109.1 | 85.7 | 133.3 | 218.9 | |
| Adjusted to add | Restructuring and other related charges(2) | 0.5 | 0.9 | 1.4 | 2.2 | 3.7 | 5.9 |
| Adjusted to add | Acquisition-amortization and other related charges(3) | 10 | 11.5 | 21.6 | 15.7 | 15.5 | 31.2 |
| Adjusted to add | Depreciation and other amortization | 3.8 | 7.6 | 11.4 | 7.7 | 13.6 | 21.4 |
| Adjusted to add | Adjusted EBITDA (non-GAAP) | 56.8 | 86.7 | 143.5 | 111.3 | 166.1 | 277.4 |
| Adjusted to add | Adjusted EBITDA attributable to Russia (non-GAAP)(4) | 5 | 5 | 11 | 11 | ||
| Adjusted to add | Core adjusted EBITDA (non-GAAP) | 56.8 | 81.7 | 138.5 | 111.3 | 155.1 | 266.4 |
| Adjusted to add | Adjusted EBITDA margin (non-GAAP) | 20.1 | 20 | 20.1 | 19.8 | 20 | 19.9 |
| Adjusted to add | Core adjusted EBITDA margin (non-GAAP)(5) | 20.1 | 20.6 | 20.4 | 19.8 | 20.4 | 20.1 |
Balance Sheet
July 3, 2026 — (Unaudited)
| July 3, 2026 | December 31, 2025 | ||
|---|---|---|---|
| CURRENT ASSETS: | Cash and cash equivalents | 217,491 | 185,863 |
| CURRENT ASSETS: | Trade receivables, less allowance for credit losses of $22,538 and $21,765 | 554,147 | 451,298 |
| CURRENT ASSETS: | Inventories, net | 581,541 | 481,765 |
| CURRENT ASSETS: | Prepaid expenses | 84,482 | 66,103 |
| CURRENT ASSETS: | Other current assets | 90,802 | 76,876 |
| CURRENT ASSETS: | Total current assets | 1,528,463 | 1,261,905 |
| CURRENT ASSETS: | Property, plant and equipment, net | 389,848 | 381,876 |
| CURRENT ASSETS: | Goodwill | 2,746,209 | 1,949,702 |
| CURRENT ASSETS: | Intangible assets, net | 1,372,088 | 673,006 |
| CURRENT ASSETS: | Lease assets - right of use | 143,382 | 113,310 |
| CURRENT ASSETS: | Other assets | 382,621 | 386,295 |
| CURRENT ASSETS: | Total assets | 6,562,611 | 4,766,094 |
| CURRENT LIABILITIES: | Current portion of debt | 5,940 | 2,412 |
| CURRENT LIABILITIES: | Accounts payable | 407,428 | 360,391 |
| CURRENT LIABILITIES: | Accrued liabilities | 365,639 | 301,986 |
| CURRENT LIABILITIES: | Total current liabilities | 779,007 | 664,789 |
| CURRENT LIABILITIES: | Long-term debt | 2,391,350 | 1,232,540 |
| CURRENT LIABILITIES: | Other liabilities | 808,037 | 657,236 |
Cash Flow
Three Months Ended — (Unaudited)
| Three Months Ended – July 3, 2026 | Three Months Ended – July 4, 2025 | Six Months Ended – July 3, 2026 | Six Months Ended – July 4, 2025 | |
|---|---|---|---|---|
| Net cash provided by operating activities (GAAP) | 33.4 | 46.6 | 80.3 | 82 |
| Purchases of property, plant and equipment (GAAP) | -17.7 | -9.2 | -31.4 | -16.5 |
| Payments related to discontinued operations | 7.5 | 4.9 | 11.8 | 7.2 |
| Acquisition-related payments(1) | 18.2 | 4 | 20.2 | 4 |
| Adjusted free cash flow (non-GAAP)(2) | 41.4 | 46.4 | 80.9 | 76.8 |
Cash Flow
Six Months Ended — (Unaudited)
| Six Months Ended – July 3, 2026 | Six Months Ended – July 4, 2025 | ||
|---|---|---|---|
| Cash flows from operating activities: | Net income | 83,225 | 137,936 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Depreciation, amortization and other impairment charges | 51,736 | 36,846 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Net gain on sale of property, plant and equipment | -60 | -5,703 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Stock-based compensation expense | 10,382 | 9,900 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Deferred income tax benefit | -15,183 | -6,761 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Amortization of debt issuance costs | 7,304 | 1,255 |
| Changes in operating assets and liabilities: | Trade receivables, net | -39,541 | -49,161 |
| Changes in operating assets and liabilities: | Inventories, net | -51,522 | -37,407 |
| Changes in operating assets and liabilities: | Accounts payable | 36,345 | 23,183 |
| Changes in operating assets and liabilities: | Other operating assets and liabilities | -2,348 | -28,051 |
| Changes in operating assets and liabilities: | Net cash provided by operating activities | 80,338 | 82,037 |
| Cash flows from investing activities: | Purchases of property, plant and equipment | -31,448 | -16,474 |
| Cash flows from investing activities: | Proceeds from sale of property, plant and equipment | 359 | 4,732 |
| Cash flows from investing activities: | Acquisitions, net of cash received | -1,469,372 | -86,252 |
| Cash flows from investing activities: | Other investing | -500 | |
| Cash flows from investing activities: | Net cash used in investing activities | -1,500,461 | -98,494 |
| Cash flows from financing activities: | Proceeds from issuance of Preferred Stock, net | 171,097 | |
| Cash flows from financing activities: | Proceeds from issuance of Common Stock, net | 139,796 | |
| Cash flows from financing activities: | Proceeds from borrowings on Senior Notes | 1,000,000 | |
| Cash flows from financing activities: | Repayments of borrowings on Term Loans | -5,000 | |
| Cash flows from financing activities: | Proceeds from borrowings on revolving credit facilities and other | 904,267 | 8,674 |
| Cash flows from financing activities: | Repayments of borrowings on revolving credit facilities and other | -730,816 | |
| Cash flows from financing activities: | Payment of debt issuance costs | -17,813 | |
| Cash flows from financing activities: | Payment of dividends | -12,201 | -9,729 |
| Cash flows from financing activities: | Distributions to noncontrolling interest holders | -1,117 | -1,174 |
| Cash flows from financing activities: | Other financing | -5,198 | -12,418 |
| Cash flows from financing activities: | Net cash provided by (used in) financing activities | 1,448,015 | -19,647 |
| Cash flows from financing activities: | Effect of foreign exchange rates on Cash and cash equivalents | 3,736 | 44,969 |
| Cash flows from financing activities: | Increase in Cash and cash equivalents | 31,628 | 8,865 |
| Cash flows from financing activities: | Cash and cash equivalents, beginning of period | 185,863 | 249,358 |
| Cash flows from financing activities: | Cash and cash equivalents, end of period | 217,491 | 258,223 |
Full release
Forward-Looking Statements
This press release includes forward-looking statements, including forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning the Company’s plans, goals, objectives, outlook, expectations, and intentions, and other statements that are not historical or current fact. Forward-looking statements are based on the Company’s current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements, including general risks and uncertainties such as market conditions, economic conditions, geopolitical events, changes in laws, regulations or accounting rules, fluctuations in interest rates, terrorism, wars or conflicts, major health concerns, natural disasters or other disruptions of expected business conditions. Factors that could cause the Company’s results to differ materially from current expectations include, but are not limited to, risks related to the impact of the war in Ukraine and the conflict in the Middle East and the resulting escalating geopolitical tensions; impact of supply chain disruptions; the impact of creditworthiness and financial viability of customers; impact of inflationary pressures, tariffs and trade policies, foreign exchange fluctuations and commodity prices; other impacts on the Company’s business and ability to execute business continuity plans; and the other factors detailed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 filed with the U.S. Securities and Exchange Commission (“SEC”) on February 20, 2026, and the Form 10-Q for the quarterly period ended April 3, 2026 filed with the SEC on May 7, 2026, as well as other risks discussed in the Company’s filings with the SEC. In addition, these statements are based on assumptions that are subject to change. This press release speaks only as of the date hereof. The Company disclaims any duty to update the information herein.
Investor Relations Contact:
Mark Barbalato
Vice President, Investor Relations
E-mail: investorrelations@esab.com
Phone:
1-301-323-9098
Media Contact:
Tilea Coleman
Vice President, Corporate Communications
E-mail: mediarelations@esab.com
Phone: 1-301-323-9092³